Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Enalapril maleate 20mg
Organon (New Zealand) Limited
Enalapril maleate 20 mg
20 mg
Tablet
Active: Enalapril maleate 20mg Excipient: Iron oxide red Iron oxide yellow Lactose monohydrate Magnesium stearate Maize starch Sodium bicarbonate Starch
Blister pack, professional sample pack, 30 tablets
Prescription
Prescription
Siegfried Evionnaz SA
Treatment of: · All grades of essential hypertension
Package - Contents - Shelf Life: Blister pack, professional sample pack - 30 tablets - 36 months from date of manufacture stored at or below 25°C. Store in a dry place - Blister pack, - 30 tablets - 36 months from date of manufacture stored at or below 25°C. Store in a dry place
1983-09-26
RENITEC ® 1 RENITEC ® _Enalapril maleate _ NEW ZEALAND CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about RENITEC. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking RENITEC against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT RENITEC IS USED FOR RENITEC lowers high blood pressure, which doctors call hypertension. It is also used to treat heart failure. HYPERTENSION Everyone has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed. There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems. You may feel fine and have no symptoms, but eventually hypertension can cause stroke, heart disease and kidney failure. RENITEC helps to lower your blood pressure. HEART FAILURE Heart failure means that the heart muscle cannot pump blood strongly enough to supply all the blood needed throughout the body. Heart failure is not the same as heart attack and does not mean that the heart stops working. Heart failure may start off with no symptoms, but as the condition progresses, patients may feel short of breath or may get tired easily after light physical activity such as walking. Some patients may wake up short of breath at night. Fluid may collect in different parts of the body, often first noticed as swollen ankles and feet. RENITEC help Read the complete document
Page 1 of 17 NEW ZEALAND DATA SHEET 1 PRODUCT NAME RENITEC ® 10 mg tablet RENITEC ® 20 mg tablet RENITEC ® M 5 mg tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each RENITEC 10 mg tablet contains 10 mg enalapril maleate Each RENITEC 20 mg tablet contains 20 mg enalapril maleate Each RENITEC M 5 mg tablet contains 5 mg enalapril maleate For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM RENITEC M 5 mg tablet: A white, barrel-shaped, biconvex tablet. The tablet is scored on one side and is engraved RENITEC on the other. Each tablet contains 5 mg of enalapril maleate. Dimensions are 8 mm x 7 mm. RENITEC 10 mg tablet: A rust-red coloured, barrel-shaped, biconvex tablet. The tablet is scored on one side and is engraved with the product name on the other side. Each tablet contains 10 mg of enalapril maleate. Dimensions are 8 mm x 7 mm. RENITEC 20 mg tablet: A peach coloured, barrel-shaped, biconvex tablet. The tablet is plain on one side and is engraved MSD 714 on the other side. Each tablet contains 20 mg of enalapril maleate. Dimensions are 8 mm x 7 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of: • All grades of essential hypertension. • Renovascular hypertension. • All degrees of heart failure. In patients with symptomatic heart failure, RENITEC is also indicated to: - Improve survival - Retard the progression of heart failure - Reduce hospitalisation for heart failure • Prevention of symptomatic heart failure. In asymptomatic patients with left ventricular dysfunction, RENITEC is indicated to: - Retard the development of symptomatic heart failure - Reduce hospitalisation for heart failure • Prevention of coronary ischaemic events in patients with left ventricular dysfunction. Page 2 of 17 RENITEC is indicated to: • Reduce the incidence of myocardial infarction • Reduce hospitalisation for unstable angina pectoris 4.2 DOSE AND METHOD OF ADMINISTRATION _DOSE _ Essential Hypertension The initial dose is 5 mg and is given once daily. The usual maintenance dos Read the complete document